Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for $128 per share in an all-cash transaction. Monsanto's Board of Directors, Bayer's Board of Management and Bayer's Supervisory Board have unanimously approved the agreement. The offer represents a premium of 44% to Monsanto's closing share price on May 9, 2016, the day before Bayer's first written proposal to Monsanto.
Morrow Sodali is serving as the proxy solicitor for Monsanto.
Related News
Sodali & Co Strengthens U.S. Corporate Governance Advisory with Appointment of Matthew Vahidi as Managing Director
13 August 2025
Entering a new phase of shareholder activism
04 August 2025
APAC teams take #1 spot in Mergermarket PR Advisor Rankings
31 July 2025
Sodali & Co Announces Three New Strategic Appointments
17 July 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right